Compare, Analyse Lupin Ltd with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

LUPIN vs ACTAVIS (US) - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More


Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More



5-Yr Chart
Click to enlarge
High Rs98613,754-   
Low Rs7209,226-   
Sales per share (Unadj.) Rs369.53,373.8-  
Earnings per share (Unadj.) Rs13.4-1,086.7-  
Cash flow per share (Unadj.) Rs37.4355.5-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.713,915.5-  
Shares outstanding (eoy) m452.49332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.33.4 67.8%   
Avg P/E ratio x63.6-10.6 -602.0%  
P/CF ratio (eoy) x22.832.3 70.6%  
Price / Book Value ratio x2.80.8 340.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,0643,821,601 10.1%   
No. of employees `00017.716.9 104.6%   
Total wages/salary Rs m31,5130-   
Avg. sales/employee Rs Th9,453.866,398.8 14.2%   
Avg. wages/employee Rs Th1,782.00-   
Avg. net profit/employee Rs Th343.0-21,387.1 -1.6%   
Net Sales Rs m167,1821,122,140 14.9%  
Other income Rs m3,64021,459 17.0%   
Total revenues Rs m170,8221,143,599 14.9%   
Gross profit Rs m28,82229,406 98.0%  
Depreciation Rs m10,850479,690 2.3%   
Interest Rs m3,07864,754 4.8%   
Profit before tax Rs m18,534-493,580 -3.8%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400125,883 -2.7%   
Tax Rs m9,017-6,255 -144.2%   
Profit after tax Rs m6,066-361,442 -1.7%  
Gross profit margin %17.22.6 657.9%  
Effective tax rate %48.71.3 3,839.0%   
Net profit margin %3.6-32.2 -11.3%  
Current assets Rs m138,536460,243 30.1%   
Current liabilities Rs m61,299407,146 15.1%   
Net working cap to sales %46.24.7 976.4%  
Current ratio x2.31.1 199.9%  
Inventory Days Days8420 427.8%  
Debtors Days Days11266 169.6%  
Net fixed assets Rs m127,516127,020 100.4%   
Share capital Rs m9050-   
"Free" reserves Rs m136,5170-   
Net worth Rs m137,4224,628,303 3.0%   
Long term debt Rs m66,4171,629,793 4.1%   
Total assets Rs m279,4947,235,091 3.9%  
Interest coverage x7.0-6.6 -106.0%   
Debt to equity ratio x0.50.4 137.3%  
Sales to assets ratio x0.60.2 385.7%   
Return on assets %3.3-4.1 -79.8%  
Return on equity %4.4-7.8 -56.5%  
Return on capital %8.9-4.8 -184.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m37,1320-   
From Operations Rs m16,660400,898 4.2%  
From Investments Rs m-32,825220,241 -14.9%  
From Financial Activity Rs m7,441-688,062 -1.1%  
Net Cashflow Rs m-8,724-66,588 13.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare LUPIN With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  


Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Oct 18, 2019 (Close)